Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 149.37

-4.5%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harvey Allen who wrote (365)	12/26/2007 11:31:48 AM
From: Bob Laz	Read Replies (1) of 395

Harey - Hope xmas was as good as can be expected - joys and pressures seem to balance out. As far as a buyout of RGEN - its a definite long shot - easier for big pharma / BMY AND OTHERS to pay the 2-6% then pay $300-$600M for the company. But still HOPE HOPE HOPE we can wake up to a DOUBLE! If Uridine passes the next P2 and with the significant market that could stimulate interest in the whole enhcilada of RGEN - as the pipleing then becomes much more significant. What was your thought on an earlier post of a generic Orencia and how would that benefit a big pharma / partnership with RGEN / once we settle would that precluse such a relationship?? The very best. Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next